DISCLAIMER This presentation contains estimates and other statistical data made by independent parties and by the Company relating to market size and growth and other data about the Company's industry and estimated total addressable market. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. Neither the Company nor any other person makes any representation as to the accuracy or completeness of such data or undertakes any obligation to ...

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Mobile-Network Solutions (MNDR) is up 96% at $3.26 - PACS Group, Inc. (PACS) is up 44% at $24.37 - Cerence Inc. (CRNC) is up 28% at $10.16 - Magnera Corporation (MAGN) is up 26% at $10.07 - Oddity Tech Ltd. (ODD) is up 17% at $43.75 - Allot Ltd. (ALLT) is up 14% at $9.80 - Artiva Biotherapeutics, Inc. (ARTV) is up 14% at $3.88 - Kulicke and Soffa Industries, Inc. (KLIC) is up 13% at $40.22 - Fossil Group, Inc. (FOSL) is up 12% at $2.29 - NVIDIA Corporation (NVDA) is up 5% at $195.84 [3] Premarket Losers - Brera Holdings PLC (SLMT) is down 33% at $3.84 - Bath & Body Works, Inc. (BBWI) is down 14% at $18.04 - Cemtrex, Inc. (CETX) is down 11% at $3.20 - Atkore Inc. (ATKR) is down 9% at $60.00 - Gloo Holdings, Inc. (GLOO) is down 9% at $7.30 - SMX (Security Matters) Public Limited Company (SMX) is down 9% at $4.60 - Sonim Technologies, Inc. (SONM) is down 8% at $7.31 - Psyence Biomedical Ltd. (PBM) is down 7% at $2.56 - MMTec, Inc. (MTC) is down 6% at $2.00 - Ridgetech, Inc. (RDGT) is down 5% at $4.78 [4]

Core Insights - Oddity Tech reported quarterly earnings of $0.4 per share, exceeding the Zacks Consensus Estimate of $0.35 per share, and showing an increase from $0.32 per share a year ago, resulting in an earnings surprise of +14.29% [1] - The company achieved revenues of $147.9 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.27% and up from $119 million year-over-year [2] Financial Performance - Over the last four quarters, Oddity Tech has consistently surpassed consensus EPS estimates [2] - The company has also topped consensus revenue estimates four times in the last four quarters [2] - The current consensus EPS estimate for the upcoming quarter is $0.14 on revenues of $149.14 million, and for the current fiscal year, it is $2.09 on revenues of $804.41 million [7] Market Position - Oddity Tech shares have underperformed the market, losing about 13% since the beginning of the year, while the S&P 500 has gained 12.5% [3] - The Zacks Rank for Oddity Tech is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Internet - Software industry, to which Oddity Tech belongs, is currently ranked in the top 24% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - ODDITY Tech Ltd. reported strong third quarter results for 2025, exceeding guidance in revenue, profit, and earnings per share, and is positioned for continued growth with new brand launches and investments in technology [2][3][4] Financial Performance - Third quarter net revenue reached $148 million, a 24% increase year-over-year from $119 million [4][6] - Gross profit for the third quarter was $106 million, up 27% from $83 million in the same period last year, with a gross margin of 71.6%, an increase of 170 basis points [4][6] - Adjusted EBITDA for the third quarter was $29 million, a 16% increase from $25 million year-over-year [4][6] - Net income for the third quarter was $18 million, consistent with the previous year, while adjusted net income rose to $25 million, a 26% increase from $20 million [4][6] Business Developments - The company successfully launched its new brand, METHODIQ, aimed at transforming the medical care system with advanced technology and precise treatments [2][5] - ODDITY is expanding its ODDITY LABS molecule discovery platform, indicating a focus on innovation and new product development [5] Financial Outlook - ODDITY raised its full-year 2025 financial outlook, projecting net revenue between $806 million and $809 million, representing a year-over-year growth of 24% to 25% [9][10] - The company anticipates a gross margin of approximately 72.5% and adjusted EBITDA between $161 million and $163 million for the full year [10] - For the fourth quarter of 2025, ODDITY expects net revenue between $149 million and $152 million, with a gross margin of approximately 69% [11]

Core Insights - Oddity Tech Ltd. is set to release its quarterly earnings on November 19, 2025, with an expected EPS of $0.35 and revenue of approximately $145.47 million [1][6] Company Developments - The launch of Methodiq, a telehealth platform for medical skincare, signifies Oddity's strategic entry into the medical-grade skincare market, competing with companies like Hims [2][6] - Methodiq offers 28 new products targeting skin conditions such as acne and eczema, with prices ranging from $29 to $59, making them accessible to a broad audience [2] - The development of Methodiq took four years and integrates investments in biotechnology and AI-based computational imaging, allowing for online diagnosis and personalized treatments [3] Financial Performance - Oddity has a price-to-earnings (P/E) ratio of 18.89, indicating the market's valuation of its earnings [4][6] - The price-to-sales ratio stands at 2.76, reflecting investor willingness to pay per dollar of sales [4] - The enterprise value to sales ratio is 1.92, showing the company's total valuation relative to its sales [4] - The company maintains a low debt-to-equity ratio of 0.065, indicating conservative debt use [5] - A current ratio of 6.32 suggests strong liquidity, ensuring the company can cover short-term liabilities [5] - An earnings yield of 5.29% demonstrates Oddity's ability to generate earnings from each dollar invested [5]

Core Insights - The consumer staples sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Company Summaries - **Oddity Tech Ltd (NASDAQ: ODD)**: - RSI Value: 29.2, indicating it is oversold - Stock price decreased by approximately 21% over the past month, with a 52-week low of $35.44 - Recent price action showed a slight increase of 0.9%, closing at $40.26 [8] - **Celsius Holdings Inc (NASDAQ: CELH)**: - RSI Value: 29.1, also indicating it is oversold - Stock price fell around 27% in the last month, reaching a 52-week low of $21.10 - The company announced a $300 million share repurchase authorization, with shares gaining 2.7% to close at $44.91 [8] - **Calavo Growers Inc (NASDAQ: CVGW)**: - RSI Value: 29.1, indicating it is oversold - Stock price decreased by about 11% over the past month, with a 52-week low of $21.46 - Recent leadership change announced, with shares falling 0.6% to close at $22.13 [8]

Core Insights - The consumer staples sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Group 1: Oversold Stocks - Oddity Tech Ltd (NASDAQ: ODD) has an RSI of 29.2, with a stock price decline of approximately 21% over the past month, closing at $40.26 [8] - Celsius Holdings Inc (NASDAQ: CELH) has an RSI of 29.1, with a stock price drop of around 27% in the last month, closing at $44.91 [8] - Calavo Growers Inc (NASDAQ: CVGW) also has an RSI of 29.1, experiencing an 11% decline in stock price over the past month, closing at $22.13 [8] Group 2: Company-Specific Developments - Oddity Tech's price target was lowered from $90 to $80 by Keybanc analyst Scott Schoenhaus [8] - Celsius Holdings announced a $300 million share repurchase authorization [8] - Calavo Growers will see a leadership change with Lee E. Cole retiring as CEO, effective December 8, 2025, and B. John Lindeman succeeding him [8]

Core Insights - The Baron International Growth Fund gained 6.04% in Q3 2025, slightly underperforming the MSCI ACWI ex USA Index which appreciated 6.89% [3][4] - The performance was influenced by the Federal Reserve's easing cycle and significant investments in AI data center capacity and GPU commitments [4] Top Contributors to Performance - Lynas Rare Earths Limited contributed 1.25% to returns, with shares nearly doubling due to geopolitical tensions highlighting the importance of non-China supply sources [5] - Argenx SE added 0.79%, driven by strong sales of its drug Vyvgart, which exceeded expectations and showed potential for growth in autoimmune conditions [6] - Lundin Mining Corporation contributed 0.66%, benefiting from solid financial results and a tightening copper supply due to competitor production suspension [7] - Taiwan Semiconductor Manufacturing Company Limited and Contemporary Amperex Technology Co., Limited also contributed positively to the Fund's performance [5] Top Detractors from Performance - Constellation Software Inc. detracted 0.70% due to uncertainty around AI's impact on software and the announcement of leadership changes [8] - InPost S.A. contributed a negative return of 0.39% as concerns arose over its largest customer Allegro exploring alternative logistics solutions [9] - ODDITY Tech Ltd. saw a decline of 0.37% despite exceeding expectations, as investors were concerned about the magnitude of the earnings beat and future cost pressures [10]

Core Insights - ODDITY Tech Ltd. will release its third quarter 2025 financial results on November 19, 2025, after market close [1] - A conference call to discuss the results will take place on November 20, 2025, at 8:30 a.m. Eastern Time [1] Company Overview - ODDITY is a consumer tech company focused on building and scaling digital-first brands in the beauty and wellness sectors [3] - The company serves approximately 60 million users through its AI-driven online platform, utilizing data science to meet consumer needs [3] - ODDITY owns brands such as IL MAKIAGE and SpoiledChild, with headquarters in New York City, an R&D center in Tel Aviv, and a biotechnology lab in Boston [3]

Core Viewpoint - Oddity Tech Ltd. is identified as an oversold mid-cap stock with significant growth potential, despite a recent price target reduction by KeyBanc Capital Markets from $90 to $80, maintaining an Overweight rating [1][2]. Group 1: Company Overview - Oddity Tech Ltd. operates as an AI-driven beauty and wellness platform, known for brands like IL MAKIAGE and SpoiledChild, utilizing machine learning and proprietary data to personalize products in skincare, cosmetics, and wellness [4]. - The company went public in 2023 and has rapidly gained attention in the digital beauty market [4]. Group 2: Financial Performance and Projections - KeyBanc projects that Oddity can achieve revenue growth exceeding 20% and long-term EBITDA margins above 20%, indicating strong potential for both top-line and margin expansion [2]. - The recent adjustment in price target is attributed to broader market trends affecting mid-cap growth stocks rather than any decline in Oddity's fundamentals [3]. Group 3: Strategic Positioning - Oddity's vertically integrated direct-to-consumer (DTC) model, along with aggressive investments in research and development, positions the company uniquely within the beauty-tech sector [3].